M&As looming larger in pharmaceutical industry

The government’s plan to cut domestic drug prices by an average of 14 percent will make it harder for companies to do business in the pharmaceutical market.

Analysts expect a large number of mergers and acquisitions (M&A) to take place among pharmaceutical companies, and restructuring seems inevitable to offset worsening profitability.

They say the problem is that there are too many playe...